Literature DB >> 19187797

Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia.

Giuseppe Sciamanna1, Paola Bonsi, Annalisa Tassone, Dario Cuomo, Anne Tscherter, Maria Teresa Viscomi, Giuseppina Martella, Nutan Sharma, Giorgio Bernardi, David G Standaert, Antonio Pisani.   

Abstract

DYT1 dystonia is caused by a deletion in a glutamic acid residue in the C-terminus of the protein torsinA, whose function is still largely unknown. Alterations in GABAergic signaling have been involved in the pathogenesis of dystonia. We recorded GABA- and glutamate-mediated synaptic currents from a striatal slice preparation obtained from a mouse model of DYT1 dystonia. In medium spiny neurons (MSNs) from mice expressing human mutant torsinA (hMT), we observed a significantly higher frequency, but not amplitude, of GABAergic spontaneous inhibitory postsynaptic currents (sIPSCs) and miniature currents (mIPSCs), whereas glutamate-dependent spontaneous excitatory synaptic currents (sEPSCs) were normal. No alterations were found in mice overexpressing normal human torsinA (hWT). To identify the possible sources of the increased GABAergic tone, we recorded GABAergic Fast-Spiking (FS) interneurons that exert a feed-forward inhibition on MSNs. However, both sEPSC and sIPSC recorded from hMT FS interneurons were comparable to hWT and non-transgenic (NT) mice. In physiological conditions, dopamine (DA) D2 receptor act presynaptically to reduce striatal GABA release. Of note, application of the D2-like receptor agonist quinpirole failed to reduce the frequency of sIPSCs in MSNs from hMT as compared to hWT and NT mice. Likewise, the inhibitory effect of quinpirole was lost on evoked IPSCs both in MSNs and FS interneurons from hMT mice. Our findings demonstrate a disinhibition of striatal GABAergic synaptic activity, that can be at least partially attributed to a D2 DA receptor dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187797      PMCID: PMC3786200          DOI: 10.1016/j.nbd.2009.01.001

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  47 in total

1.  Retrograde endocannabinoid signaling in a postsynaptic neuron/synaptic bouton preparation from basolateral amygdala.

Authors:  Ping Jun Zhu; David M Lovinger
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

2.  Dopaminergic modulation of short-term synaptic plasticity at striatal inhibitory synapses.

Authors:  Fatuel Tecuapetla; Luis Carrillo-Reid; José Bargas; Elvira Galarraga
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-01       Impact factor: 11.205

3.  Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope.

Authors:  Rose E Goodchild; Connie Eunji Kim; William T Dauer
Journal:  Neuron       Date:  2005-12-22       Impact factor: 17.173

4.  Depolarization-induced suppression of inhibition mediated by endocannabinoids at synapses from fast-spiking interneurons to medium spiny neurons in the striatum.

Authors:  Madoka Narushima; Motokazu Uchigashima; Kouichi Hashimoto; Masahiko Watanabe; Masanobu Kano
Journal:  Eur J Neurosci       Date:  2006-10-17       Impact factor: 3.386

5.  Heteromeric nicotinic acetylcholine-dopamine autoreceptor complexes modulate striatal dopamine release.

Authors:  Davide Quarta; Francisco Ciruela; Kshitij Patkar; Janusz Borycz; Marcello Solinas; Carme Lluis; Rafael Franco; Roy A Wise; Steven R Goldberg; Bruce T Hope; Amina S Woods; Sergi Ferré
Journal:  Neuropsychopharmacology       Date:  2006-05-17       Impact factor: 7.853

6.  Tonic enhancement of endocannabinoid-mediated retrograde suppression of inhibition by cholinergic interneuron activity in the striatum.

Authors:  Madoka Narushima; Motokazu Uchigashima; Masahiro Fukaya; Minoru Matsui; Toshiya Manabe; Kouichi Hashimoto; Masahiko Watanabe; Masanobu Kano
Journal:  J Neurosci       Date:  2007-01-17       Impact factor: 6.167

7.  Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.

Authors:  Tohru Kitada; Antonio Pisani; Douglas R Porter; Hiroo Yamaguchi; Anne Tscherter; Giuseppina Martella; Paola Bonsi; Chen Zhang; Emmanuel N Pothos; Jie Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

8.  Dopamine release is impaired in a mouse model of DYT1 dystonia.

Authors:  Aygul Balcioglu; Mee-Ohk Kim; Nutan Sharma; Jang-Ho Cha; Xandra O Breakefield; David G Standaert
Journal:  J Neurochem       Date:  2007-04-30       Impact factor: 5.372

9.  Functional and ultrastructural analysis of group I mGluR in striatal fast-spiking interneurons.

Authors:  Paola Bonsi; Giuseppe Sciamanna; Darlene A Mitrano; Dario Cuomo; Giorgio Bernardi; Paola Platania; Yoland Smith; Antonio Pisani
Journal:  Eur J Neurosci       Date:  2007-03       Impact factor: 3.386

10.  Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells.

Authors:  Jeffrey W Hewett; Bakhos Tannous; Brian P Niland; Flavia C Nery; Juan Zeng; Yuqing Li; Xandra O Breakefield
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-11       Impact factor: 11.205

View more
  37 in total

Review 1.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

Review 2.  Engineering animal models of dystonia.

Authors:  Janneth Oleas; Fumiaki Yokoi; Mark P DeAndrade; Antonio Pisani; Yuqing Li
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

3.  Opposite effects of stimulant and antipsychotic drugs on striatal fast-spiking interneurons.

Authors:  Alexander B Wiltschko; Jeffrey R Pettibone; Joshua D Berke
Journal:  Neuropsychopharmacology       Date:  2010-01-20       Impact factor: 7.853

4.  Deep-Brain Stimulation for Basal Ganglia Disorders.

Authors:  Thomas Wichmann; Mahlon R Delong
Journal:  Basal Ganglia       Date:  2011-07-01

Review 5.  Alternative approaches to modeling hereditary dystonias.

Authors:  Rachel Fremont; Kamran Khodakhah
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

6.  Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia.

Authors:  Giuseppe Sciamanna; Annalisa Tassone; Georgia Mandolesi; Francesca Puglisi; Giulia Ponterio; Giuseppina Martella; Graziella Madeo; Giorgio Bernardi; David G Standaert; Paola Bonsi; Antonio Pisani
Journal:  J Neurosci       Date:  2012-08-29       Impact factor: 6.167

Review 7.  Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.

Authors:  Samuel S Pappas; Daniel K Leventhal; Roger L Albin; William T Dauer
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

8.  Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.

Authors:  Morvarid Karimi; Stephen M Moerlein; Tom O Videen; Yi Su; Hubert P Flores; Joel S Perlmutter
Journal:  Mov Disord       Date:  2013-10-21       Impact factor: 10.338

Review 9.  Basal ganglia mechanisms in action selection, plasticity, and dystonia.

Authors:  Jonathan W Mink
Journal:  Eur J Paediatr Neurol       Date:  2018-01-17       Impact factor: 3.140

Review 10.  Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.